2026 NURSING NCLEX EXAM GRADES A + WITH RELEVANT
SOLUTIONS TO QUESTIONS
1. Question
A patient is admitted to the same-day surgery unit for liver biopsy. Which of the
following laboratory tests assesses coagulation? Select all that apply.
A. Partial thromboplastin time.
Correct Answer
B. Prothrombin time.
Correct Answer
C. Platelet count.
Correct Answer
D. Hemoglobin
Incorrect
E. Complete Blood Count
F. White Blood Cell Count
Incorrect
Correct Answer: A, B, and C
,Prothrombin time, partial thromboplastin time, and platelet count are all included
in coagulation studies. The hemoglobin level, though important information prior
to an invasive procedure like liver biopsy, does not assess coagulation.
Option A: Partial thromboplastin time (PTT) is the time it takes for a patient’s
blood to form a clot as measured in seconds. It is used to measure the activity of
the intrinsic pathway of the clotting cascade. PTT tests the function of all clotting
factors except factor VII (tissue factor) and factor XIII (fibrin stabilizing factor).
Option B: Prothrombin time (PT) is one of several blood tests routinely used in
clinical practice to evaluate the coagulation status of patients. More specifically,
PT is used to evaluate the extrinsic and common pathways of coagulation, which
would detect deficiencies of factors II, V, VII, and X, and low fibrinogen
concentrations.
Option C: Platelet count is being assessed to determine the number of platelets in
a sample of the blood as part of a health exam; to screen for, diagnose, or
monitor conditions that affect the number of platelets, such as a bleeding
disorder, a bone marrow disease, or other underlying conditions.
Option D: Hemoglobin is used to evaluate the hemoglobin content of your blood
as part of a general health checkup; to screen for and help diagnose conditions
that affect red blood cells (RBCs); if there is anemia (low hemoglobin) or
polycythemia (high hemoglobin), and to assess the severity of these conditions
and to monitor response to treatment.
,Option E: The complete blood count (CBC) is a group of tests that evaluate the
cells that circulate in blood, including red blood cells (RBCs), white blood cells
(WBCs), and platelets (PLTs). The CBC can evaluate your overall health and detect
a variety of diseases and conditions, such as infections, anemia and leukemia.
Option F: WBC count is used to screen for or diagnose a variety of conditions that
can affect the number of white blood cells (WBCs), such as an infection,
inflammation or a disease that affects WBCs; to monitor treatment of a disorder
or to monitor therapy that is known to affect WBCs
2. Question
A patient is admitted to the hospital with suspected polycythemia vera. Which of
the following symptoms is consistent with the diagnosis? Select all that apply.
A. Weight loss.
B. Prolonged clotting time.
Correct Answer
C. Hypertension.
Correct Answer
D. Headaches.
Correct Answer
E. Polyphagia
F. Pruritus
, Correct
Incorrect
Correct Answer: B, C, D, and F.
Polycythemia vera is a condition in which the bone marrow produces too many
red blood cells. This causes an increase in hematocrit and viscosity of the blood.
Patients can experience headaches, dizziness, and visual disturbances. Bleeding is
also a complication, possibly because the platelets are often very large and
somewhat dysfunctional. The bleeding can be significant and can occur in the
form of nosebleeds, ulcers, frank GI bleeding, hematuria, and intracranial
hemorrhage.
Option A: Weight loss is not a manifestation of polycythemia vera. Weight loss
may result from early satiety or from the increased myeloproliferative activity of
the abnormal clone.
Option B: Patients with polycythemia vera are at increased risk for thrombosis
that may result in CVAs (strokes, brain attacks) or myocardial infarctions (MIs);
thrombotic complications are the most common cause of death.
Option C: Cardiovascular effects include increased blood pressure and delayed
clotting time. Thrombotic complications (1%) include venous thrombosis or
thromboembolism and an increased prevalence of stroke and other arterial
thrombosis.
SOLUTIONS TO QUESTIONS
1. Question
A patient is admitted to the same-day surgery unit for liver biopsy. Which of the
following laboratory tests assesses coagulation? Select all that apply.
A. Partial thromboplastin time.
Correct Answer
B. Prothrombin time.
Correct Answer
C. Platelet count.
Correct Answer
D. Hemoglobin
Incorrect
E. Complete Blood Count
F. White Blood Cell Count
Incorrect
Correct Answer: A, B, and C
,Prothrombin time, partial thromboplastin time, and platelet count are all included
in coagulation studies. The hemoglobin level, though important information prior
to an invasive procedure like liver biopsy, does not assess coagulation.
Option A: Partial thromboplastin time (PTT) is the time it takes for a patient’s
blood to form a clot as measured in seconds. It is used to measure the activity of
the intrinsic pathway of the clotting cascade. PTT tests the function of all clotting
factors except factor VII (tissue factor) and factor XIII (fibrin stabilizing factor).
Option B: Prothrombin time (PT) is one of several blood tests routinely used in
clinical practice to evaluate the coagulation status of patients. More specifically,
PT is used to evaluate the extrinsic and common pathways of coagulation, which
would detect deficiencies of factors II, V, VII, and X, and low fibrinogen
concentrations.
Option C: Platelet count is being assessed to determine the number of platelets in
a sample of the blood as part of a health exam; to screen for, diagnose, or
monitor conditions that affect the number of platelets, such as a bleeding
disorder, a bone marrow disease, or other underlying conditions.
Option D: Hemoglobin is used to evaluate the hemoglobin content of your blood
as part of a general health checkup; to screen for and help diagnose conditions
that affect red blood cells (RBCs); if there is anemia (low hemoglobin) or
polycythemia (high hemoglobin), and to assess the severity of these conditions
and to monitor response to treatment.
,Option E: The complete blood count (CBC) is a group of tests that evaluate the
cells that circulate in blood, including red blood cells (RBCs), white blood cells
(WBCs), and platelets (PLTs). The CBC can evaluate your overall health and detect
a variety of diseases and conditions, such as infections, anemia and leukemia.
Option F: WBC count is used to screen for or diagnose a variety of conditions that
can affect the number of white blood cells (WBCs), such as an infection,
inflammation or a disease that affects WBCs; to monitor treatment of a disorder
or to monitor therapy that is known to affect WBCs
2. Question
A patient is admitted to the hospital with suspected polycythemia vera. Which of
the following symptoms is consistent with the diagnosis? Select all that apply.
A. Weight loss.
B. Prolonged clotting time.
Correct Answer
C. Hypertension.
Correct Answer
D. Headaches.
Correct Answer
E. Polyphagia
F. Pruritus
, Correct
Incorrect
Correct Answer: B, C, D, and F.
Polycythemia vera is a condition in which the bone marrow produces too many
red blood cells. This causes an increase in hematocrit and viscosity of the blood.
Patients can experience headaches, dizziness, and visual disturbances. Bleeding is
also a complication, possibly because the platelets are often very large and
somewhat dysfunctional. The bleeding can be significant and can occur in the
form of nosebleeds, ulcers, frank GI bleeding, hematuria, and intracranial
hemorrhage.
Option A: Weight loss is not a manifestation of polycythemia vera. Weight loss
may result from early satiety or from the increased myeloproliferative activity of
the abnormal clone.
Option B: Patients with polycythemia vera are at increased risk for thrombosis
that may result in CVAs (strokes, brain attacks) or myocardial infarctions (MIs);
thrombotic complications are the most common cause of death.
Option C: Cardiovascular effects include increased blood pressure and delayed
clotting time. Thrombotic complications (1%) include venous thrombosis or
thromboembolism and an increased prevalence of stroke and other arterial
thrombosis.
